Skip to main content

Pharmaceuticals

Key Green Chemistry research areas from a pharmaceutical manufacturers’ perspective revisited

The ACS Green Chemistry Institute® Pharmaceutical Roundtable (GCIPR) was developed in 2005 to encourage the integration of green chemistry and green engineering into the pharmaceutical industry. One of the strategic priorities of the Roundtable is to inform and influence the research agenda and an early step was the publication of a paper on key green chemistry research areas (KRA) from a pharmaceutical manufacturers’ perspective. The publication was followed up with the ongoing GCIPR Research Grant Programme.

Embedding sustainable practices into pharmaceutical R&D: what are the challenges?

The world's population is predicted to exceed 9 billion by 2050, with growth in the developing world projected to triple global resource consumption. Industries, including pharmaceuticals, will still be competing for one Earth's worth of resources to meet this tripled demand. In order to thrive in the future, it is clear that routes to pharmaceuticals, which currently produce in the order of 100 kg of waste for each kilogram of drug in an optimized process, will need to be more efficient and sustainable.

Practical Green Chemistry Tools and Techniques for Research & Development Scientists

picture from workshop

This free workshop offered at the ACS Spring 2024 meeting in New Orleans will equip industry-based R&D chemists and engineers, as well as graduate students, with practical green chemistry tools, methods, and metrics. The content of this workshop will cover green chemistry basics through to the most recent innovative tools and metrics widely used in the pharmaceutical industry. The workshop will be tailored toward scientists and engineers working in batch chemical operations in common use within the pharma industry, but the tools may be applied to other allied chemical industries (e.g.

Peter J. Dunn Award for Green Chemistry & Engineering Impact in the Pharmaceutical Industry

Purpose:

The Peter J. Dunn Award was established in 2016 by the ACS GCI Pharmaceutical Roundtable (ACS GCIPR) to recognize excellence in the research, development, and execution of green chemistry that demonstrates compelling environmental, safety, and efficiency improvements over current technologies in the pharmaceutical industry and its allied industrial partners. The inaugural award was given to Peter J. Dunn of Pfizer and subsequently named in his honor.

opn2EXPERTS: Our scientific questions for experts

Rolling Grant Cycles - With our opn2EXPERTS program, we invite you to explore novel solutions for discovery research that will benefit the future unmet needs of patients. Every question will address precisely described problems. The submission period will be limited. However, we may leave some solved questions on the portal in case you have a very good idea at a later stage. All incoming proposals will be reviewed by our scientific juries.

Subscribe to Pharmaceuticals